Medicare, Medicaid Coverage Of Obesity Drugs Would Add $40bn In Government Spending

 
• By Cathy Kelly
  
CMS may have underestimated the cost of covering obesity medications. (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Drug Pricing

More from Market Access